why are glp-1 drugs so expensive worth their current cost? Why Are GLP-1 Medications So

These results are sustained long-term too, with 10.2% average weight loss maintained at four years when consistently using the medication

Study endpoints The primary endpoint was the percentage weight loss at M6 compared to baseline

others discontinue due to nausea or side effects

The team at Novo were confident that the Wegovy pill would be approved

Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

Patients must often submit proof of failed diet-and-exercise attempts, BMI thresholds, and comorbidity documentation before insurers will even review claims